These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 25088505)

  • 1. Risk of bleeding and adverse outcomes predicted by thromboelastography platelet mapping in patients taking clopidogrel within 7 days of non-cardiac surgery.
    Kasivisvanathan R; Abbassi-Ghadi N; Kumar S; Mackenzie H; Thompson K; James K; Mallett SV
    Br J Surg; 2014 Oct; 101(11):1383-90. PubMed ID: 25088505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet activity measured by a rapid turnaround assay identifies coronary artery bypass grafting patients at increased risk for bleeding and transfusion complications after clopidogrel administration.
    Rosengart TK; Romeiser JL; White LJ; Fratello A; Fallon E; Senzel L; Shroyer AL
    J Thorac Cardiovasc Surg; 2013 Nov; 146(5):1259-1266, 1266.e1; discussion 1266. PubMed ID: 23953984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does the VerifyNow P2Y12 assay overestimate "therapeutic response" to clopidogrel? Insights using short thrombelastography.
    Khanna V; Hobson A; Mikael R; Sambu N; Englyst N; Curzen N
    Thromb Haemost; 2014 Jun; 111(6):1150-9. PubMed ID: 24671606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of P2Y12 inhibition by clopidogrel on cardiovascular mortality in unselected patients treated by percutaneous coronary angioplasty: a prospective registry.
    El Ghannudi S; Ohlmann P; Meyer N; Wiesel ML; Radulescu B; Chauvin M; Bareiss P; Gachet C; Morel O
    JACC Cardiovasc Interv; 2010 Jun; 3(6):648-56. PubMed ID: 20630458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of individual responses to clopidogrel: Validation of a novel, rapid analysis using thrombelastography 6s.
    Olechowski B; Dalton RT; Khanna V; Ashby A; Vavyla M; Mariathas M; Harris S; Nicholas Z; Mahmoudi M; Curzen N
    Cardiovasc Ther; 2018 Aug; 36(4):e12433. PubMed ID: 29682911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenosine diphosphate-induced single-platelet count aggregation and bleeding in clopidogrel-treated patients undergoing coronary artery bypass grafting.
    Dalén M; van der Linden J; Holm M; Lindvall G; Ivert T
    J Cardiothorac Vasc Anesth; 2014 Apr; 28(2):230-4. PubMed ID: 24447500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clopidogrel (Plavix) and cardiac surgical patients: implications for platelet function monitoring and postoperative bleeding.
    Tanaka KA; Szlam F; Kelly AB; Vega JD; Levy JH
    Platelets; 2004 Aug; 15(5):325-32. PubMed ID: 15370104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thromboelastograph with Platelet Mapping(TM) predicts postoperative chest tube drainage in patients undergoing coronary artery bypass grafting.
    Chowdhury M; Shore-Lesserson L; Mais AM; Leyvi G
    J Cardiothorac Vasc Anesth; 2014 Apr; 28(2):217-23. PubMed ID: 24630471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical implications of very low on-treatment platelet reactivity in patients treated with thienopyridine: the POBA study (predictor of bleedings with antiplatelet drugs).
    Cuisset T; Grosdidier C; Loundou AD; Quilici J; Loosveld M; Camoin L; Pankert M; Beguin S; Lambert M; Morange PE; Bonnet JL; Alessi MC
    JACC Cardiovasc Interv; 2013 Aug; 6(8):854-63. PubMed ID: 23968703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laboratory assessments of therapeutic platelet inhibition in endovascular neurosurgery: complication prediction using the VerifyNow P2Y12 assay and thromboelastography with platelet mapping.
    Corliss BM; Freedman R; Brennan MM; Smith J; Nerva JD; Harris NS; Polifka AJ; Hoh BL; Fox WC
    J Neurosurg; 2021 Mar; 134(3):884-892. PubMed ID: 32084635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does clopidogrel increase blood loss following coronary artery bypass surgery?
    Chu MW; Wilson SR; Novick RJ; Stitt LW; Quantz MA
    Ann Thorac Surg; 2004 Nov; 78(5):1536-41. PubMed ID: 15511426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of clopidogrel premedication in off-pump cardiac surgery: are we forfeiting the benefits of reduced hemorrhagic sequelae?
    Kapetanakis EI; Medlam DA; Petro KR; Haile E; Hill PC; Dullum MK; Bafi AS; Boyce SW; Corso PJ
    Circulation; 2006 Apr; 113(13):1667-74. PubMed ID: 16567570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Switching acute coronary syndrome patients from prasugrel to clopidogrel.
    Kerneis M; Silvain J; Abtan J; Cayla G; O'Connor SA; Barthélémy O; Vignalou JB; Beygui F; Brugier D; Martin R; Collet JP; Montalescot G
    JACC Cardiovasc Interv; 2013 Feb; 6(2):158-65. PubMed ID: 23428007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Individualized strategy for clopidogrel suspension in patients undergoing off-pump coronary surgery for acute coronary syndrome: a case-control study.
    Mannacio V; Meier P; Antignano A; Di Tommaso L; De Amicis V; Vosa C
    J Thorac Cardiovasc Surg; 2014 Oct; 148(4):1299-306. PubMed ID: 24503325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Premature preoperative discontinuation of antiplatelet drug therapy in cardiovascular risk patients: a preliminary study on the role of P2Y12 receptor monitoring.
    Metzler H; Prüller F; Münch A; Primus G; Kainz J; Hödl R; Rehak P
    Eur J Anaesthesiol; 2010 Feb; 27(2):138-45. PubMed ID: 19593147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma sequestration: a good therapy to prevent the deleterious effect of clopidogrel when clopidogrel is used within one to four days of coronary bypass surgery.
    Schill DM
    Perfusion; 2010 Mar; 25(2):91-5. PubMed ID: 20427413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between ABCB1 polymorphisms, thromboelastography and risk of bleeding events in clopidogrel-treated patients with ST-elevation myocardial infarction.
    Zhang JH; Tang XF; Zhang Y; Wang J; Yao Y; Ma YL; Xu B; Gao RL; Gao Z; Chen J; Song L; Wu Y; Meng XM; Yuan JQ
    Thromb Res; 2014 Nov; 134(5):970-5. PubMed ID: 25217066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clopidogrel treatment before coronary artery bypass graft surgery increases postoperative morbidity and blood product requirements.
    Filsoufi F; Rahmanian PB; Castillo JG; Kahn RA; Fischer G; Adams DH
    J Cardiothorac Vasc Anesth; 2008 Feb; 22(1):60-6. PubMed ID: 18249332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of antiplatelet efficacy and tolerability of clopidogrel napadisilate with clopidogrel bisulfate in coronary artery disease patients after percutaneous coronary intervention: a prospective, multicenter, randomized, open-label, phase IV, noninferiority trial.
    Park JB; Koo BK; Choi WG; Kim SY; Park J; Kwan J; Park CG; Kim HS
    Clin Ther; 2013 Jan; 35(1):28-37.e4. PubMed ID: 23328268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response variability to P2Y12 receptor inhibitors: expectations and reality.
    Siller-Matula JM; Trenk D; Schrör K; Gawaz M; Kristensen SD; Storey RF; Huber K;
    JACC Cardiovasc Interv; 2013 Nov; 6(11):1111-28. PubMed ID: 24262612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.